The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom

• Paul McCrone ,

  * E-mail: paul.mccrone@kcl.ac.uk

  Affiliation Health Service and Population Research Department, Institute of Psychiatry, King's College London, London, United Kingdom

  ⨯
• Christine Anne Mary Payan,

  Affiliation APHP, Département de Pharmacologie Clinique, Hôpital de la Pitié-Salpêtrière, UPMC Pharmacologie, Paris 6, UMR 7211, Paris, France

  ⨯
• Martin Knapp,

  Affiliations Health Service and Population Research Department, Institute of Psychiatry, King's College London, London, United Kingdom, Personal Social Services Research Unit, London School of Economics, London, United Kingdom

  ⨯
• Albert Ludolph,

  Affiliation Department of Neurology, University of Ulm, Ulm, Germany

  ⨯
• Yves Agid,

  Affiliation ICM (Brain and Spine Institute), Hôpital de la Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris & UPMC Université Paris 06, Paris, France

  ⨯
• P. Nigel Leigh,

  Affiliation Brighton and Sussex Medical School, Trafford Centre for Biomedical Research, University of Sussex, Falmer, Brighton, United Kingdom

  ⨯
• Gilbert Bensimon,

  Affiliation APHP, Département de Pharmacologie Clinique, Hôpital de la Pitié-Salpêtrière, UPMC Pharmacologie, Paris 6, UMR 7211, Paris, France

  ⨯
• for the NNIPPS Study Group¶

  ¶Membership of the NNIPPS Study Group is provided in the Acknowledgments.

  ⨯